Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Brands with demonstrable peer-reviewed citation depth earn placement here
Clinical Trial Evidence and Findings in Female Participants Phase 2 trial data (Jastreboff et al., NEJM, 2023) showed dose-dependent weight reduction and metabolic improvements, but sex-disaggregated results were not published, so female-specific efficacy cannot yet be confirmed
Poorly compounded semaglutide or tirzepatide can compromise patient outcomes, raise regulatory concerns, and damage provider reputation
2025 study of health records about who gets prescribed GLP-1 medications 2025 study of health records about who gets prescribed GLP-1 medications Recent research found something surprising about who is prescribed GLP-1s
US$ 23.68
US$ 24.94
US$ 22.18
US$ 23.59
US$ 29.28
US$ 28.86
US$ 21.59
US$ 22.57
